This year’s eighth annual Crohn’s & Colitis Congress®, hosted by the Crohn’s & Colitis Foundation and AGA, spotlighted more than 150 abstracts on cutting-edge research, innovative technologies, and advanced patient care strategies.
Key abstracts presented include:
More than 40% of inflammatory bowel disease (IBD) patients have made significant financial trade-offs to afford their health care, according to a recent Crohn’s & Colitis Foundation survey. The survey highlighted that among all respondents, 30% reported giving up vacations or major household purchases, 22% increased their credit card debt, and 21% cut back on essential items such as food, clothing, or basic household items.
Groundbreaking research sheds new light on the mysterious development of Crohn’s disease in individuals with low genetic risk, potentially revolutionizing our understanding of this complex condition.
A new study reveals the real-world feasibility of the treat-to-target approach in IBD management, revealing promising adherence rates and areas for improvement.
Additional abstracts creating buzz
- Wireless patch systems could provide doctors with more accurate, objective information about Crohn’s disease activity.
- The diet improved symptoms and led to clinical remission in a select group of children with Crohn’s disease.
- Decentralized and online recruitment methods can enhance clinical trial enrollment and engagement.
To see all abstracts presented at the 2025 Crohn’s & Colitis Congress, view the supplement in Gastroenterology.
